Consequently, anti-tumoral activity of B-cL1 was evaluated by VEGF-induced (50 ng/ml) human gastric cancer SGC-7901 cell proliferation and on BALB/c mice subcutaneous xenograft of human gastric cancer SGC-7901 cells. This evidence concerns the gene VEGFA and gastric cancer.